Cefonicid

• Description :

  Pharmacokinetic studies of Cefonicid have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H312-H332

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/cefonicid.html

• Smiles :

  O=C(O)C(N12)=C(CSC3=NN=NN3CS(=O)(O)=O)CS[C@]2([H])[C@H](NC([C@H](O)C4=CC=CC=C4)=O)C1=O

• Molecular Formula :

  C18H18N6O8S3

• Molecular Weight :

  542.57

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations :

  [1]Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30 (5) : 587-593.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [61270-58-4]